Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
194.14
188.61
173.01
207.97
184.97
188.10
144.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
194.14
188.61
173.01
207.97
184.97
188.10
144.33
Raw Material Cost
50.31
51.53
32.79
37.91
33.77
27.65
21.08
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
53.19
52.64
41.69
40.30
30.53
32.78
26.75
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.46
0.69
0.69
0.73
0.02
0.02
0.02
Selling and Distribution Expenses
73.07
71.84
69.64
60.82
48.40
57.74
44.11
Other Expenses
-3.32
-2.64
-2.99
-1.74
-0.96
-1.48
-1.42
Total Expenditure (Excl Depreciation)
143.80
150.31
114.88
122.34
103.09
103.43
77.76
Operating Profit (PBDIT) excl Other Income
50.300000000000004
38.3
58.099999999999994
85.60000000000001
81.89999999999999
84.7
66.6
Other Income
20.12
17.86
23.66
9.41
9.84
5.33
12.87
Operating Profit (PBDIT)
86.75
68.27
89.66
106.43
96.72
94.58
70.51
Interest
0.46
0.69
0.69
0.73
0.02
0.02
0.02
Exceptional Items
-4.97
2.59
2.66
0.15
0.00
0.12
0.00
Gross Profit (PBDT)
143.83
137.08
140.22
170.07
151.20
160.45
123.25
Depreciation
20.34
17.40
15.14
15.28
12.75
10.93
9.47
Profit Before Tax
60.98
52.77
76.50
90.58
83.95
83.75
61.03
Tax
6.28
6.64
9.84
11.39
11.58
12.01
10.42
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
44.29
38.77
64.20
76.48
63.17
65.76
42.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
44.29
38.77
64.20
76.48
63.17
65.76
42.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
44.29
38.77
64.20
76.48
63.17
65.76
42.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,095.50
1,085.84
1,121.63
369.63
293.15
336.94
256.88
Earnings per share (EPS)
0.41
0.36
0.59
0.71
0.58
0.61
0.39
Diluted Earnings per share
0.41
0.36
0.59
0.71
0.58
0.61
0.39
Operating Profit Margin (Excl OI)
23.84%
17.5%
29.4%
39.3%
40.08%
41.64%
33.38%
Gross Profit Margin
41.89%
37.2%
52.97%
50.9%
52.28%
50.34%
48.85%
PAT Margin
22.81%
20.56%
37.11%
36.78%
34.15%
34.96%
29.14%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 2.92% vs 9.02% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 14.18% vs -39.56% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 32.14% vs -23.64% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -28.57% vs 0.00% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Shanghai Serum Bio-Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
194.14
0
194.14
Other Operating Income
0.00
0.00
0.00
Total Operating income
194.14
0
194.14
Raw Material Cost
50.31
0
50.31
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
53.19
0
53.19
Power Cost
0
0
0.00
Manufacturing Expenses
0.46
0
0.46
Selling and Distribution Expenses
73.07
0
73.07
Other Expenses
-3.32
0.00
-3.32
Total Expenditure (Excl Depreciation)
143.80
0
143.80
Operating Profit (PBDIT) excl Other Income
50.34
0.00
50.34
Other Income
20.12
0
20.12
Operating Profit (PBDIT)
86.75
0
86.75
Interest
0.46
0
0.46
Exceptional Items
-4.97
0
-4.97
Gross Profit (PBDT)
143.83
0
143.83
Depreciation
20.34
0
20.34
Profit Before Tax
60.98
0
60.98
Tax
6.28
0
6.28
Provisions and contingencies
0
0
0.00
Profit After Tax
44.29
0
44.29
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
44.29
0
44.29
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
44.29
0
44.29
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,095.50
0
1,095.50
Earnings per share (EPS)
0.41
0
0.41
Diluted Earnings per share
0.41
0
0.41
Operating Profit Margin (Excl OI)
23.84%
0%
0.00
23.84%
Gross Profit Margin
41.89%
0%
0.00
41.89%
PAT Margin
22.81%
0%
0.00
22.81%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 19.41 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 2.92% vs 9.02% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 4.43 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 14.18% vs -39.56% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.66 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 32.14% vs -23.64% in Dec 2023
Annual - Interest
Interest 0.05 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -28.57% vs 0.00% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.84%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






